Labetuzumab Govitecan Biosimilar - Research Grade,ichor.bio,ICH5617G
Host
CHO Cells
Reactivity
Human
Platform ID
BAB511975956

ichor.bio
Contact
Tel:
Fax:
Email:
Product Specifications
Scientific Background
Synonyms
Specifications
NameLabetuzumab Govitecan Biosimilar - Research Grade
Cat. No.ICH5617G
HostCHO Cells
IsotypeIgG1
ReactivityHuman
Concentration1mg/ml
TargetCEACAM5 / CEA / CD66e
Purity>90% by SDS-PAGE
ShippingRoom Temp
StorageThis biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Regulatory StatusFor research use only
Scientific Background
Labetuzumab Govitecan is an antibody-drug conjugate (ADC) containing labetuzumab, a mildly reduced, anti-CEACAM5 humanized monoclonal antibody, conjugated to the potent topoisomerase I inhibitor SN-38, with antineoplastic activity.
Synonyms
SN38
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.
